Periplaneta americana extract attenuates hepatic fibrosis progression by inhibiting collagen synthesis and regulating the TGF-β1/Smad signaling pathway
Abstract
Introduction. Liver fibrosis is the damage repair response following chronic liver diseases. Activated hepatic stellate cells (HSCs) are the main extracellular matrix (ECM)-producing cells and key regulators in liver fibrosis. Periplaneta americana shows prominent antifibrotic effects in liver fibrosis; however, the underlying mechanisms remain undetermined. This study aimed to elucidate the therapeutic effects of P. americana extract (PA-B) on liver fibrosis based on the regulation of the TGF-β1/Smad signal pathway.
Material and methods. HSCs and Sprague Dawley rats were treated with TGF-β1 and CCl4, respectively, to establish the hepatic fibrosis model in vitro and in vivo. The effect of PA-B on liver rat fibrosis was evaluated by biochemical (serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), hyaluronic acid (HA), laminin (LN), collagen type IV (Col-IV), pro-collagen type III (PC-III)) and histological examinations. Further, fibrogenic markers expression of alpha smooth muscle actin (α-SMA), collagen type I (Col-I), and collagen type III (Col-III), and the TGF-β1/Smad pathway-related factors were assessed by immunofluorescence (IF), real time quantitative polymerase chain reaction (RT-qPCR), and western blotting (WB).
Results. Treatment of HSC-T6 cells with PA-B suppressed the expression of α-SMA, Col-I, and Col-III, downregulated the expression of TGF-β1 receptors I and II (TβR I and TβR II, respectively), Smad2, and Smad3, and upregulated Smad7 expression. PA-B mitigates pathologic changes in the rat model of liver fibrosis, thus alleviating liver index, and improving liver function and fibrosis indices. The effects of PA-B on the expression of α-SMA, Col-I, Col-III, TβR I, TβR II, Smad2, Smad3, and Smad7 were consistent with the in vitro results, including reduced TGF-β1 expression.
Conclusions. The therapeutic effect of PA-B on liver fibrosis might involve suppression of the secretion and expression of TGF-β1, regulation of the TGF-β1/Smad signaling pathway, and inhibition of collagen production and secretion.
Keywords: Liver fibrosisPeriplaneta americana extractHSC-T6 cellscollagen type Icollagen type IIITGF-β1/Smad pathway
References
- Shan L, Wang F, Zhai D, et al. New Drugs for Hepatic Fibrosis. Front Pharmacol. 2022; 13: 874408.
- Roehlen N, Crouchet E, Baumert TF. Liver fibrosis: mechanistic concepts and therapeutic perspectives. Cells. 2020; 9(4).
- Wang YH, Twu YC, Wang CK, et al. Niemann-Pick type C2 protein regulates free cholesterol accumulation and influences hepatic stellate cell proliferation and mitochondrial respiration function. Int J Mol Sci. 2018; 19(6).
- Lu P, Yan M, He Li, et al. Crosstalk between epigenetic modulations in valproic acid deactivated hepatic stellate cells: an integrated protein and miRNA profiling study. Int J Biol Sci. 2019; 15(1): 93–104.
- Lo RC, Kim H. Histopathological evaluation of liver fibrosis and cirrhosis regression. Clin Mol Hepatol. 2017; 23(4): 302–307.
- Tsuchida T, Friedman SL. Mechanisms of hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol. 2017; 14(7): 397–411.
- Zhangdi HJ, Su SB, Wang F, et al. Crosstalk network among multiple inflammatory mediators in liver fibrosis. World J Gastroenterol. 2019; 25(33): 4835–4849.
- Li D, Ma D, Liu Ye, et al. Extracts of Periplaneta americana alleviate hepatic fibrosis by affecting hepatic TGF-β and NF-κB expression in rats with pig serum-induced liver fibrosis. Folia Histochem Cytobiol. 2022; 60(2): 125–135.
- Inagaki Y, Okazaki I. Emerging insights into Transforming growth factor beta Smad signal in hepatic fibrogenesis. Gut. 2007; 56(2): 284–292.
- Sun WY, Gu YJ, Li XR, et al. β-arrestin2 deficiency protects against hepatic fibrosis in mice and prevents synthesis of extracellular matrix. Cell Death Dis. 2020; 11(5): 389.
- Loboda A, Sobczak M, Jozkowicz A, et al. TGF-β1/Smads and miR-21 in renal fibrosis and inflammation. Mediators Inflamm. 2016; 2016: 8319283.
- Chen L, Yang T, Lu DW, et al. Central role of dysregulation of TGF-β/Smad in CKD progression and potential targets of its treatment. Biomed Pharmacother. 2018; 101: 670–681.
- Jiang Y, Xiang C, Zhong F, et al. Histone H3K27 methyltransferase EZH2 and demethylase JMJD3 regulate hepatic stellate cells activation and liver fibrosis. Theranostics. 2021; 11(1): 361–378.
- Saito A, Horie M, Nagase T. TGF-β signaling in lung health and disease. Int J Mol Sci. 2018; 19(8).
- Hahn O, Ingwersen LC, Soliman A, et al. TGF-ß1 induces changes in the energy metabolism of white adipose tissue-derived human adult mesenchymal stem/stromal cells . Metabolites. 2020; 10(2).
- He X, Cheng R, Huang C, et al. A novel role of LRP5 in tubulointerstitial fibrosis through activating TGF-β/Smad signaling. Signal Transduct Target Ther. 2020; 5(1): 45.
- Yoshida K, Murata M, Yamaguchi T, et al. TGF-β/Smad signaling during hepatic fibro-carcinogenesis (review). Int J Oncol. 2014; 45(4): 1363–1371.
- Cheng Qi, Li C, Yang CF, et al. Methyl ferulic acid attenuates liver fibrosis and hepatic stellate cell activation through the TGF-β1/Smad and NOX4/ROS pathways. Chem Biol Interact. 2019; 299: 131–139.
- Yang YX, Luo Qi, Hou Bo, et al. Periplanosides A-C: new insect-derived dihydroisocoumarin glucosides from Periplaneta americana stimulating collagen production in human dermal fibroblasts. J Asian Nat Prod Res. 2015; 17(10): 988–995.
- Yun J, Hwang JS, Lee DG. The antifungal activity of the peptide, periplanetasin-2, derived from American cockroach . Biochem J. 2017; 474(17): 3027–3043.
- Gao Y, Liang LC, Wang R, et al. Chemical constituents from Periplaneta americana. Chin Tradit Patent Med. 2018; 40: 375–378.
- Si JG, Zhang T, Li LY, et al. Chemical constituents from Periplaneta Americana. Chin Pharm J. 2018; 53(3): 178–181.
- Wang Q, Liu K, Kong C, et al. Current situation on antioxidant stress and active compounds of Periplaneta americana extracts. Chin Arch Tradi Chin Med. 2021; 39: 124–127.
- Gao YY, Geng FN, Chen SM, et al. Advances in research on active ingredients and related pharmacology of Periplaneta americana. Chin J Exp Tradit Med Form. 2021; 24: 240–250.
- Gu T, Yang YS, Xie JJ, et al. Effects of active extracts from Periplaneta Americana on treating hepatic fibrosis in rats by gastric and intestinal administration. J Dali Univ. 2021; 6: 18–22.
- Fu W, Zhao Y, Xie J, et al. Identification of anti-hepatic fibrosis components in Periplaneta americana based on spectrum-effect relationship and chemical component separation. Biomed Chromatogr. 2022; 36(3): e5286.
- Naik N, Madani A, Esteva A, et al. Deep learning-enabled breast cancer hormonal receptor status determination from base-level H&E stains. Nat Commun. 2020; 11(1): 5727.
- Iezzoni JC. Diagnostic histochemistry in hepatic pathology. Semin Diagn Pathol. 2018; 35(6): 381–389.
- Ghasemzadeh N, Pourrajab F, Dehghani Firoozabadi A, et al. Ectopic microRNAs used to preserve human mesenchymal stem cell potency and epigenetics. EXCLI J. 2018; 17: 576–589.
- Shi WP, Ju Di, Li H, et al. CD147 promotes CXCL1 expression and modulates liver fibrogenesis. Int J Mol Sci. 2018; 19(4).
- Seki E, Schwabe RF. Hepatic inflammation and fibrosis: functional links and key pathways. Hepatology. 2015; 61(3): 1066–1079.
- Ezhilarasan D, Sokal E, Najimi M. Hepatic fibrosis: It is time to go with hepatic stellate cell-specific therapeutic targets. Hepatobiliary Pancreat Dis Int. 2018; 17(3): 192–197.
- Shi W, An Li, Zhang J, et al. extract ameliorates lipopolysaccharide-induced liver injury by improving mitochondrial dysfunction via the AMPK/PGC-1α signaling pathway. Exp Ther Med. 2021; 22(4): 1138.
- Yuan L, Yang X, He Y, et al. Mechanism of the anti-liver fibrosis effect of Periplaneta americana extracts that promote apoptosis of HSC-T6 cells through the Bcl-2/Bax signaling pathway. J Asia-Pac Entomol. 2023; 26(2): 102094.
- Gasparyan AY, Ayvazyan L, Yessirkepov M, et al. Colchicine as an anti-inflammatory and cardioprotective agent. Expert Opin Drug Metab Toxicol. 2015; 11(11): 1781–1794.
- Liu H, Zhang Z, Hu H, et al. Protective effects of Liuweiwuling tablets on carbon tetrachloride-induced hepatic fibrosis in rats. BMC Complement Altern Med. 2018; 18(1): 212.
- López-Hernández FJ, López-Novoa JM. Role of TGF-β in chronic kidney disease: an integration of tubular, glomerular and vascular effects. Cell Tissue Res. 2012; 347(1): 141–154.
- Song L, Qu D, Zhang Q, et al. Phytosterol esters attenuate hepatic steatosis in rats with non-alcoholic fatty liver disease rats fed a high-fat diet. Sci Rep. 2017; 7: 41604.
- Yanguas SC, Cogliati B, Willebrords J, et al. Experimental models of liver fibrosis. Arch Toxicol. 2016; 90(5): 1025–1048.
- Tang G, Seume N, Häger C, et al. Comparing distress of mouse models for liver damage. Sci Rep. 2020; 10(1): 19814.
- Manibusan MK, Odin M, Eastmond DA. Postulated carbon tetrachloride mode of action: a review. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2007; 25(3): 185–209.
- Tabrez S, Ahmad M. Effect of wastewater intake on antioxidant and marker enzymes of tissue damage in rat tissues: implications for the use of biochemical markers. Food Chem Toxicol. 2009; 47(10): 2465–2478.
- Liang L, Yang X, Yu Y, et al. Babao Dan attenuates hepatic fibrosis by inhibiting hepatic stellate cells activation and proliferation via TLR4 signaling pathway. Oncotarget. 2016; 7(50): 82554–82566.
- Stanko P, Baka T, Repova K, et al. Ivabradine Ameliorates Kidney Fibrosis in L-NAME-Induced Hypertension. Front Med (Lausanne). 2020; 7: 325.
- Chen X, Li HD, Bu FT, et al. Circular RNA circFBXW4 suppresses hepatic fibrosis via targeting the miR-18b-3p/FBXW7 axis. Theranostics. 2020; 10(11): 4851–4870.
- Dawood RM, El-Meguid MA, Salum GM, et al. Key players of hepatic fibrosis. J Interferon Cytokine Res. 2020; 40(10): 472–489.
- Yang HY, Kim KS, Lee YH, et al. Ameliorates Thioacetamide-Induced Hepatic Fibrosis via TGF-β1/Smads Pathways. Int J Biol Sci. 2019; 15(4): 800–811.
- Zhang L, Liu C, Meng XM, et al. Smad2 protects against TGF-β1/Smad3-mediated collagen synthesis in human hepatic stellate cells during hepatic fibrosis. Mol Cell Biochem. 2015; 400(1-2): 17–28.
- Xu F, Liu C, Zhou D, et al. TGF-β/SMAD pathway and its regulation in hepatic fibrosis. J Histochem Cytochem. 2016; 64(3): 157–167.
- Sferra R, Vetuschi A, Pompili S, et al. Expression of pro-fibrotic and anti-fibrotic molecules in dimethylnitrosamine-induced hepatic fibrosis. Pathol Res Pract. 2017; 213(1): 58–65.
- Yang N, Dang S, Shi J, et al. Caffeic acid phenethyl ester attenuates liver fibrosis via inhibition of TGF-β1/Smad3 pathway and induction of autophagy pathway. Biochem Biophys Res Commun. 2017; 486(1): 22–28.
- Hu HH, Chen DQ, Wang YN, et al. New insights into TGF-β/Smad signaling in tissue fibrosis. Chem Biol Interact. 2018; 292: 76–83.
- Ebeid DE, Khalafalla FG, Broughton KM, et al. Pim1 maintains telomere length in mouse cardiomyocytes by inhibiting TGFβ signalling. Cardiovasc Res. 2021; 117(1): 201–211.
